© Shutterstock
Blood tests - highlighting potential demand for multiplex platforms
A team from the NIHR Community Healthcare MIC analysed data from over 11.7 million laboratory blood tests.
Read morePoint-of-care flu tests don't lower antibiotic prescribing, study finds
Tests also have no effect on admission or return visits, finds research published in Clinical Infectious Diseases.
Read moreDiagnostics to meet real clinical need
The NIHR Community Healthcare MedTech and In Vitro Diagnostics Co-operative (MIC) brings together experienced health researchers, industry, end users and clinical experts in the development and evaluation of diagnostic tests that transform community healthcare by working with industry to deliver studies in the NHS.
> Who are we? > Contact us
Industry
We advise on the suitability of new technologies and the evidence required to support their commercial uptake.
Clinicians
We broker collaborations between industry and clinical practice to test new technologies in community settings.
Patients
Our public contributors help steer and govern our work to ensure it is relevant to patients and carers.
Funding opportunities
We work collaboratively with SMEs to develop funded studies that further test and develop new technologies. Current funding opportunities include:
-
Wellcome Trust Innovator Awards
- NIHR Invention for Innovation
- Biomedical Catalyst Primer Award
- Biomedical Catalyst Late Stage Award
Latest news
Register for our newsletter
Get details on the latest news, opportunities and upcoming events with our quarterly email bulletin. You may also register for our public newsletter, produced in partnership with the University of Oxford and the NIHR CLAHRC Oxford.
Join our LinkedIn Group
Join the In Vitro Diagnostics in Primary Care LinkedIn Group and share your own news and opportunities with clinicians, researchers, industry representatives and healthcare delivery professionals.